Abstract

The field of primary liver cancer has changed very fast. In old days this disease was barely known to scientists and developers, and this could be detected only at the last stages and was treated based on the symptoms of the patients. At present it has became an area of huge research interest – there have been major breakthroughs in the understanding and emphasizing of its pathogenesis, as well as in the development of diagnostic tools and therapeutic options. Still, the clinical management of Hepato Cellular Carcinoma (HCC) and Intra hepatic Cholangio Carcinoma (iCCA) remains complicated and requires a multifaceted management team including hepatologists, oncologists, liver surgeons, radiologists and pathologists.

Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call